Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose reappraisal of Pudilan Xiaoyan oral liquid in adults with acute pharyngitis or tonsillitis
ChiCTR1900025731Phase 4Not yet recruiting
- Sponsor
- Liaoning Provincial Academy of Traditional Chinese Medicine
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Pudilan Xiaoyan in acute pharyngitis and tonsillitis (6 arms), sponsored by Liaoning Provincial Academy of Traditional Chinese Medicine. Primary endpoint: Total effective rate of pharyngalgia. Planned start Dec 2018; status: not yet recruiting.
02
Drugs
Pudilan Xiaoyan
03
Conditions
acute pharyngitistonsillitis
Beyond the preview
Go deeper on ChiCTR1900025731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025731.